About this trial
This study intends to retrospectively-prospectively enroll NVM patients from multiple centers to establish a natural population cohort of NVM patients. By collecting clinical data and biological samples from surgical patients, the investigators will construct a prognosis prediction system for NVM, optimize risk stratification, explore new strategies for the early prevention and treatment of NVM, and improve the efficiency of clinical treatment of NVM patients.
Eligibility criteria
Qualifiers
The diagnosis of nvm was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing.
Patients or their families agreed to participate in the study and authorized informed consent.
Disqualifiers
Incomplete clinical data.
Do not agree to the inclusion or refuse to authorize the informed consent.
Trial design
Treatments tested in this trial
- Diagnosis of NVM
- Diagnosis of NVM
- Diagnosis of NVM